These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36385261)

  • 21. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
    Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
    Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study.
    Hjuler T; Wohlfahrt J; Simonsen J; Kaltoft MS; Koch A; Kamper-Jørgensen M; Biggar RJ; Melbye M
    Clin Infect Dis; 2007 Apr; 44(8):1051-6. PubMed ID: 17366448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-control study of malignant and non-malignant respiratory disease among employees of a fiberglass manufacturing facility. II. Exposure assessment.
    Chiazze L; Watkins DK; Fryar C; Kozono J
    Br J Ind Med; 1993 Aug; 50(8):717-25. PubMed ID: 8398858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Spicer JO; Thomas S; Holst A; Baughman W; Farley MM
    Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
    Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
    Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
    Sadlier C; O'Connell S; Kelleher M; Bergin C
    Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study.
    Barricarte A; Castilla J; Gil-Setas A; Torroba L; Navarro-Alonso JA; Irisarri F; Arriazu M
    Clin Infect Dis; 2007 Jun; 44(11):1436-41. PubMed ID: 17479939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults.
    Baxter R; Yee A; Aukes L; Snow V; Fireman B; Atkinson B; Klein NP
    Vaccine; 2016 Aug; 34(36):4293-7. PubMed ID: 27396493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands.
    Wagenvoort GH; Knol MJ; de Melker HE; Vlaminckx BJ; van der Ende A; Rozenbaum MH; Sanders EA
    Vaccine; 2016 Jan; 34(3):334-40. PubMed ID: 26647289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
    Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
    PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.
    Ciruela P; Soldevila N; Hernández S; Selva L; de Sevilla MF; García-García JJ; Moraga F; Planes AM; Muñoz-Almagro C; Domínguez A
    Vaccine; 2013 Jan; 31(6):960-6. PubMed ID: 23261046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Cancer in Children of Parents Occupationally Exposed to Hydrocarbon Solvents and Engine Exhaust Fumes: A Register-Based Nested Case-Control Study from Sweden (1960-2015).
    Rossides M; Kampitsi CE; Talbäck M; Mogensen H; Wiebert P; Feychting M; Tettamanti G
    Environ Health Perspect; 2022 Jul; 130(7):77002. PubMed ID: 35857399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
    Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
    Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.
    Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
    Clin Infect Dis; 2013 Mar; 56(5):633-40. PubMed ID: 23175560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility to severe infection in families with invasive pneumococcal disease.
    Hjuler T; Poulsen G; Wohlfahrt J; Kaltoft M; Biggar RJ; Melbye M
    Am J Epidemiol; 2008 Apr; 167(7):814-9. PubMed ID: 18227098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.
    von Mollendorf C; von Gottberg A; Tempia S; Meiring S; de Gouveia L; Quan V; Lengana S; Avenant T; du Plessis N; Eley B; Finlayson H; Reubenson G; Moshe M; O'Brien KL; Klugman KP; Whitney CG; Cohen C;
    Clin Infect Dis; 2015 May; 60(9):1346-56. PubMed ID: 25645212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.